[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
arrow_back TREATMENTS
Bispecific Antibodies (BsAb)
Bispecific antibodies act as a go-between, recognizing and attaching to cancer cells and joining them to the immune system’s T cells. That cancer cell-to-T cell attachment results in the T cells attacking cancer cells.
Talquetamab (Talvey®) VIEW TREATMENT Elranatamab (Elrexfrio™) VIEW TREATMENT Teclistamab (Tecvayli®) VIEW TREATMENT
newsletter icon

Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive

Follow Us

facebook instagram linkedin tiktok youtube